Delaware | 001-41406 | 47-2409192 | ||||||
(State or Other Jurisdiction | (Commission File Number) | (IRS Employer | ||||||
of Incorporation) | Identification No.) |
☐ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, par value $0.01 per share | EHAB | New York Stock Exchange |
Exhibit Number |
Description | |||||||
104 | Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document. |
ENHABIT, INC. | ||||||||
By: | /s/ Dylan Black | |||||||
Name: | Dylan Black | |||||||
Title: | General Counsel |
($ in millions, except per share data) | Q4 | '23 vs. '22 | ||||||||||||||||||
2023 | 2022 | |||||||||||||||||||
Home health net service revenue | $ | 209.5 | $ | 215.8 | (2.9)% | |||||||||||||||
Hospice net service revenue | 51.1 | 47.4 | 7.8% | |||||||||||||||||
Total net service revenue | $ | 260.6 | $ | 263.2 | (1.0)% | |||||||||||||||
% of Revenue | % of Revenue | |||||||||||||||||||
Cost of services | 51.2% | $ | 133.5 | 50.6% | $ | 133.3 | 0.2% | |||||||||||||
Gross margin | 48.8% | 127.1 | 49.4% | 129.9 | (2.2)% | |||||||||||||||
General and administrative expenses | 38.9% | 101.4 | 38.0% | 100.0 | 1.4% | |||||||||||||||
Total operating expenses | 90.1% | $ | 234.9 | 88.6% | $ | 233.3 | 0.7% | |||||||||||||
Other income | — | 0.9 | ||||||||||||||||||
Net income attributable to noncontrolling interests | 0.5 | 0.5 | ||||||||||||||||||
Adjusted EBITDA | $ | 25.2 | $ | 30.3 | (16.8)% | |||||||||||||||
Adjusted EBITDA margin | 9.7% | 11.5% | ||||||||||||||||||
Impairment of goodwill | $ | — | $ | (109.0) | N/A | |||||||||||||||
Net loss attributable to Enhabit, Inc. | $ | (6.4) | $ | (95.2) | 93.3% | |||||||||||||||
Reported diluted EPS | $ | (0.13) | $ | (1.91) | 93.2% | |||||||||||||||
Adjusted EPS | $ | 0.06 | $ | 0.17 | (64.7)% |
($ in millions) | Q4 | '23 vs. '22 | ||||||||||||
2023 | 2022 | |||||||||||||
Net service revenue | $ | 209.5 | $ | 215.8 | (2.9)% | |||||||||
Cost of services | 109.4 | 109.0 | 0.4% | |||||||||||
Gross margin | 47.8% | 49.5% | ||||||||||||
General and administrative expenses | $ | 59.3 | $ | 60.0 | (1.2)% | |||||||||
Other income | $ | — | $ | (0.9) | (100.0)% | |||||||||
Equity earnings / noncontrolling interest | $ | 0.5 | $ | 0.5 | —% | |||||||||
Adjusted EBITDA | $ | 40.3 | $ | 47.2 | (14.6)% | |||||||||
% Adj. EBITDA margin | 19.2% | 21.9% | ||||||||||||
Operational metrics (Actual Amounts) | ||||||||||||||
Starts of care | ||||||||||||||
Episodic admissions | 31,243 | 34,572 | (9.6)% | |||||||||||
Non-episodic admissions | 20,764 | 15,476 | 34.2% | |||||||||||
Total admissions | 52,007 | 50,048 | 3.9% | |||||||||||
Same-store total admissions growth | 3.2% | |||||||||||||
Episodic recertifications | 22,849 | 25,279 | (9.6)% | |||||||||||
Non-episodic recertifications | 9,179 | 7,104 | 29.2% | |||||||||||
Total recertifications | 32,028 | 32,383 | (1.1)% | |||||||||||
Same-store total recertifications growth | (1.7)% | |||||||||||||
Total starts of care | 84,035 | 82,431 | 1.9% | |||||||||||
Completed episodes | 54,108 | 60,250 | (10.2)% | |||||||||||
Revenue per episode | $ | 2,924 | $ | 2,958 | (1.1)% | |||||||||
Visits per episode | 14.3 | 14.3 | —% | |||||||||||
Total visits | 1,162,385 | 1,159,420 | 0.3% | |||||||||||
Non-episodic visits | 387,055 | 297,350 | 30.2% | |||||||||||
Cost per visit | $ | 92 | $ | 92 | —% |
($ in millions) | Q4 | '23 vs. '22 | ||||||||||||
2023 | 2022 | |||||||||||||
Net service revenue | $ | 51.1 | $ | 47.4 | 7.8% | |||||||||
Cost of services | 24.0 | 24.3 | (1.2)% | |||||||||||
Gross margin | 53.0% | 48.7% | ||||||||||||
General and administrative expenses | $ | 15.4 | $ | 17.5 | (12.0)% | |||||||||
Equity earnings / noncontrolling interest | $ | — | $ | — | ||||||||||
Adjusted EBITDA | $ | 11.7 | $ | 5.6 | 108.9% | |||||||||
% Adj. EBITDA margin | 22.9% | 11.8% | ||||||||||||
Operational metrics (Actual Amounts) | ||||||||||||||
Total admissions | 2,872 | 2,915 | (1.5)% | |||||||||||
Same-store total admissions growth | (3.8)% | |||||||||||||
Patient days | 315,870 | 330,102 | (4.3)% | |||||||||||
Discharged average length of stay | 102 | 110 | (7.3)% | |||||||||||
Average daily census | 3,433 | 3,588 | (4.3)% | |||||||||||
Revenue per day | $ | 162 | $ | 144 | 12.5% | |||||||||
Cost per day | $ | 76 | $ | 74 | 2.7% |
Full-year 2024 | Guidance | |||||||
Net Service Revenue | between $1,076 and $1,102 million | |||||||
Adjusted EBITDA | between $98 and $110 million | |||||||
Adjusted EPS | between $0.12 and $0.43 |
Three Months Ended December 31, | For the Year Ended December 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
(In Millions, Except Per Share Data) | |||||||||||||||||||||||
Net service revenue | $ | 260.6 | $ | 263.2 | $ | 1,046.3 | $ | 1,071.1 | |||||||||||||||
Cost of service, excluding depreciation and amortization | 133.5 | 133.3 | 535.6 | 525.6 | |||||||||||||||||||
General and administrative expenses | 114.5 | 104.6 | 441.6 | 414.9 | |||||||||||||||||||
Depreciation and amortization | 7.7 | 8.3 | 30.9 | 33.0 | |||||||||||||||||||
Impairment of goodwill | — | 109.0 | 85.8 | 109.0 | |||||||||||||||||||
Operating income (loss) | 4.9 | (92.0) | (47.6) | (11.4) | |||||||||||||||||||
Interest expense and amortization of debt discounts and fees | 12.3 | 8.7 | 43.0 | 15.0 | |||||||||||||||||||
Other income | — | (0.9) | (0.2) | (0.9) | |||||||||||||||||||
Loss before income taxes and noncontrolling interests | (7.4) | (99.8) | (90.4) | (25.5) | |||||||||||||||||||
Income tax (benefit) expense | (1.5) | (5.1) | (11.4) | 12.8 | |||||||||||||||||||
Net loss | (5.9) | (94.7) | (79.0) | (38.3) | |||||||||||||||||||
Less: Net income attributable to noncontrolling interests | 0.5 | 0.5 | 1.5 | 2.1 | |||||||||||||||||||
Net loss attributable to Enhabit, Inc. | $ | (6.4) | $ | (95.2) | $ | (80.5) | $ | (40.4) | |||||||||||||||
Weighted average common shares outstanding: | |||||||||||||||||||||||
Basic | 50.0 | 49.7 | 49.9 | 49.7 | |||||||||||||||||||
Diluted | 50.0 | 49.8 | 49.9 | 49.7 | |||||||||||||||||||
Loss per common share: | |||||||||||||||||||||||
Basic loss per share attributable to Enhabit, Inc. common stockholders | $ | (0.13) | $ | (1.92) | $ | (1.61) | $ | (0.81) | |||||||||||||||
Diluted loss per share attributable to Enhabit, Inc. common stockholders | $ | (0.13) | $ | (1.91) | $ | (1.61) | $ | (0.81) |
December 31, 2023 |
December 31, 2022 |
||||||||||
(In Millions) | |||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 27.4 | $ | 22.9 | |||||||
Restricted cash | 2.4 | 4.3 | |||||||||
Accounts receivable, net of allowances | 164.7 | 149.6 | |||||||||
Income tax receivable | 3.0 | 11.4 | |||||||||
Prepaid expenses and other current assets | 12.6 | 23.6 | |||||||||
Total current assets | 210.1 | 211.8 | |||||||||
Property and equipment, net | 19.0 | 20.4 | |||||||||
Operating lease right-of-use assets | 57.5 | 42.0 | |||||||||
Goodwill | 1,061.7 | 1,144.8 | |||||||||
Intangible assets, net | 80.0 | 102.6 | |||||||||
Other long-term assets | 5.3 | 5.2 | |||||||||
Total assets | $ | 1,433.6 | $ | 1,526.8 | |||||||
Liabilities and Stockholders’ Equity | |||||||||||
Current liabilities: | |||||||||||
Current portion of long-term debt | $ | 22.5 | $ | 23.1 | |||||||
Current portion of operating lease liabilities | 11.8 | 14.0 | |||||||||
Accounts payable | 7.6 | 3.8 | |||||||||
Accrued payroll | 38.5 | 35.5 | |||||||||
Refunds due patients and other third-party payors | 8.2 | 8.3 | |||||||||
Accrued medical insurance | 8.4 | 7.5 | |||||||||
Other current liabilities | 40.7 | 40.7 | |||||||||
Total current liabilities | 137.7 | 132.9 | |||||||||
Long-term debt, net of current portion | 530.1 | 560.0 | |||||||||
Long-term operating lease liabilities, net of current portion | 45.7 | 28.1 | |||||||||
Deferred income tax liabilities | 17.1 | 28.6 | |||||||||
Other long-term liabilities | 1.3 | 1.9 | |||||||||
731.9 | 751.5 | ||||||||||
Commitments and contingencies | |||||||||||
Redeemable noncontrolling interests | 5.0 | 5.2 | |||||||||
Stockholders’ equity: | |||||||||||
Total Enhabit, Inc. stockholders’ equity | 669.7 | 741.7 | |||||||||
Noncontrolling interests | 27.0 | 28.4 | |||||||||
Total stockholders’ equity | 696.7 | 770.1 | |||||||||
Total liabilities and stockholders’ equity | $ | 1,433.6 | $ | 1,526.8 |
For the Year Ended December 31, | |||||||||||
2023 | 2022 | ||||||||||
($ in millions) | |||||||||||
Cash flows from operating activities: | |||||||||||
Net loss | $ | (79.0) | $ | (38.3) | |||||||
Adjustments to reconcile net loss to net cash provided by operating activities— | |||||||||||
Depreciation and amortization | 30.9 | 33.0 | |||||||||
Amortization of debt related costs | 2.1 | 0.6 | |||||||||
Impairment of goodwill | 85.8 | 109.0 | |||||||||
Stock-based compensation | 8.9 | 9.2 | |||||||||
Deferred tax benefit | (11.6) | (4.3) | |||||||||
Other, net | (0.4) | 0.1 | |||||||||
Changes in assets and liabilities, net of acquisitions — | |||||||||||
Accounts receivable, net of allowances | (14.6) | 21.6 | |||||||||
Prepaid expenses and other assets | 19.1 | (27.5) | |||||||||
Accounts payable | 3.8 | 0.2 | |||||||||
Accrued payroll | 3.0 | (31.0) | |||||||||
Other liabilities | 0.4 | 7.5 | |||||||||
Net cash provided by operating activities | 48.4 | 80.1 | |||||||||
Cash flows from investing activities: | |||||||||||
Acquisition of businesses, net of cash acquired | (2.8) | (36.3) | |||||||||
Purchases of property and equipment, including capitalized software costs | (3.5) | (7.1) | |||||||||
Other | 1.0 | 1.1 | |||||||||
Net cash used in investing activities | (5.3) | (42.3) | |||||||||
Cash flows from financing activities: | |||||||||||
Principal borrowings on term loan | — | 400.0 | |||||||||
Principal payments on debt | (20.0) | (10.0) | |||||||||
Borrowings on revolving credit facility | — | 190.0 | |||||||||
Payments on revolving credit facility | (10.0) | — | |||||||||
Principal payments under finance lease obligations | (3.4) | (5.0) | |||||||||
Debt issuance costs | (3.2) | (4.7) | |||||||||
Distributions paid to noncontrolling interests of consolidated affiliates | (3.2) | — | |||||||||
Contributions from Encompass | — | 59.8 | |||||||||
Distributions to Encompass | — | (654.9) | |||||||||
Contributions from noncontrolling interests of consolidated affiliates | — | 7.4 | |||||||||
Other | (0.7) | (1.2) | |||||||||
Net cash used in financing activities | (40.5) | (18.6) | |||||||||
Increase in cash, cash equivalents, and restricted cash | 2.6 | 19.2 | |||||||||
Cash, cash equivalents, and restricted cash at beginning of year | 27.2 | 8.0 | |||||||||
Cash, cash equivalents, and restricted cash at end of year | $ | 29.8 | $ | 27.2 | |||||||
Three Months Ended December 31, |
Year Ended December 31, |
||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Diluted earnings per share, as reported | $ | (0.13) | $ | (1.91) | $ | (1.61) | $ | (0.81) | |||||||||||||||
Adjustments, net of tax: | |||||||||||||||||||||||
Impairment of goodwill | — | 1.91 | 1.50 | 1.91 | |||||||||||||||||||
Unusual or nonrecurring items that are not typical of ongoing operations(1) |
0.18 | 0.05 | 0.32 | 0.14 | |||||||||||||||||||
Income tax adjustments(2) |
0.01 | 0.12 | 0.02 | 0.12 | |||||||||||||||||||
Adjusted earnings per share(3) |
$ | 0.06 | $ | 0.17 | $ | 0.22 | $ | 1.36 |
Three Months Ended December 31, | |||||||||||||||||||||||
2023 | |||||||||||||||||||||||
Adjustments | |||||||||||||||||||||||
As Reported | Unusual or nonrecurring items that are not typical of ongoing operations | Income Tax Adjustments(3) |
As Adjusted | ||||||||||||||||||||
($ in millions, except per share data) | |||||||||||||||||||||||
Adjusted EBITDA(1) |
$ | 25.2 | $ | — | $ | — | $ | 25.2 | |||||||||||||||
Interest expense and amortization of debt discounts & fees | (12.3) | — | — | (12.3) | |||||||||||||||||||
Unusual or nonrecurring items that are not typical of ongoing operations(2) |
(11.4) | 11.4 | — | — | |||||||||||||||||||
Depreciation and amortization | (7.7) | — | — | (7.7) | |||||||||||||||||||
Stock-based compensation | (1.7) | — | — | (1.7) | |||||||||||||||||||
Net (loss) income before income taxes, including noncontrolling interests | (7.9) | 11.4 | — | 3.5 | |||||||||||||||||||
Income tax benefit (expense) | 1.5 | (2.2) | 0.3 | (0.4) | |||||||||||||||||||
Net (loss) income attributable to Enhabit | $ | (6.4) | $ | 9.2 | $ | 0.3 | $ | 3.1 | |||||||||||||||
Diluted earnings per share(4) |
$ | (0.13) | $ | 0.18 | $ | 0.01 | $ | 0.06 | |||||||||||||||
Diluted shares | 50.0 | 50.0 |
Three Months Ended December 31, | |||||||||||||||||||||||||||||
2022 | |||||||||||||||||||||||||||||
Adjustments | |||||||||||||||||||||||||||||
As Reported | Impairment of Goodwill | Unusual or nonrecurring items that are not typical of ongoing operations | Income Tax Adjustments(3) |
As Adjusted | |||||||||||||||||||||||||
($ in millions, except per share data) | |||||||||||||||||||||||||||||
Adjusted EBITDA(1) |
$ | 30.3 | $ | — | $ | — | $ | — | $ | 30.3 | |||||||||||||||||||
Impairment of goodwill | (109.0) | 109.0 | — | — | — | ||||||||||||||||||||||||
Interest expense and amortization of debt discounts & fees | (8.7) | — | — | — | (8.7) | ||||||||||||||||||||||||
Depreciation and amortization | (8.3) | — | — | — | (8.3) | ||||||||||||||||||||||||
Unusual or nonrecurring items that are not typical of ongoing operations(2) |
(2.5) | — | 2.5 | — | — | ||||||||||||||||||||||||
Stock-based compensation | (2.1) | — | — | — | (2.1) | ||||||||||||||||||||||||
Net (loss) income before income taxes, including noncontrolling interests | (100.3) | 109.0 | 2.5 | — | 11.2 | ||||||||||||||||||||||||
Income tax benefit (expense) | 5.1 | (13.7) | (0.6) | 6.2 | (3.0) | ||||||||||||||||||||||||
Net (loss) income attributable to Enhabit | $ | (95.2) | $ | 95.3 | $ | 1.9 | $ | 6.2 | $ | 8.2 | |||||||||||||||||||
Diluted earnings per share(4) |
$ | (1.91) | $ | 1.91 | $ | 0.05 | $ | 0.12 | $ | 0.17 | |||||||||||||||||||
Diluted shares | 49.8 | 49.8 |
Year Ended December 31, | |||||||||||||||||||||||||||||
2023 | |||||||||||||||||||||||||||||
Adjustments | |||||||||||||||||||||||||||||
As Reported | Impairment of Goodwill | Unusual or nonrecurring items that are not typical of ongoing operations | Income Tax Adjustments(3) |
As Adjusted | |||||||||||||||||||||||||
($ in millions, except per share data) | |||||||||||||||||||||||||||||
Adjusted EBITDA(1) |
$ | 97.6 | $ | — | $ | — | $ | — | $ | 97.6 | |||||||||||||||||||
Impairment of goodwill | (85.8) | 85.8 | — | — | — | ||||||||||||||||||||||||
Interest expense and amortization of debt discounts & fees | (43.0) | — | — | — | (43.0) | ||||||||||||||||||||||||
Depreciation and amortization | (30.9) | — | — | — | (30.9) | ||||||||||||||||||||||||
Unusual or nonrecurring items that are not typical of ongoing operations (2) |
(21.2) | — | 21.2 | — | — | ||||||||||||||||||||||||
Stock-based compensation | (8.9) | — | — | — | (8.9) | ||||||||||||||||||||||||
Gain on disposal or impairment of assets | 0.3 | — | — | — | 0.3 | ||||||||||||||||||||||||
Net (loss) income before income taxes, including noncontrolling interests | (91.9) | 85.8 | 21.2 | — | 15.1 | ||||||||||||||||||||||||
Income tax benefit (expense) | 11.4 | (11.1) | (5.1) | 0.9 | (3.9) | ||||||||||||||||||||||||
Net (loss) income attributable to Enhabit | $ | (80.5) | $ | 74.7 | $ | 16.1 | $ | 0.9 | $ | 11.2 | |||||||||||||||||||
Diluted earnings per share(4) |
$ | (1.61) | $ | 1.50 | $ | 0.32 | $ | 0.02 | $ | 0.22 | |||||||||||||||||||
Diluted shares | 49.9 | 49.9 |
Year Ended December 31, | |||||||||||||||||||||||||||||
2022 | |||||||||||||||||||||||||||||
Adjustments | |||||||||||||||||||||||||||||
As Reported | Impairment of Goodwill | Unusual or nonrecurring items that are not typical of ongoing operations | Income Tax Adjustments(3) |
As Adjusted | |||||||||||||||||||||||||
($ in millions, except per share data) | |||||||||||||||||||||||||||||
Adjusted EBITDA(1) |
$ | 149.3 | $ | — | $ | — | $ | — | $ | 149.3 | |||||||||||||||||||
Impairment of goodwill | (109.0) | 109.0 | — | — | — | ||||||||||||||||||||||||
Depreciation and amortization | (33.0) | — | — | — | (33.0) | ||||||||||||||||||||||||
Interest expense and amortization of debt discounts & fees | (15.0) | — | — | — | (15.0) | ||||||||||||||||||||||||
Unusual or nonrecurring items that are not typical of ongoing operations(2) |
(9.5) | — | 9.5 | — | — | ||||||||||||||||||||||||
Stock-based compensation | (9.2) | — | — | — | (9.2) | ||||||||||||||||||||||||
Stock-based compensation included in overhead allocation | (1.1) | — | — | — | (1.1) | ||||||||||||||||||||||||
Loss on disposal or impairment of assets | (0.1) | — | — | — | (0.1) | ||||||||||||||||||||||||
Net (loss) income before income taxes, including noncontrolling interests | (27.6) | 109.0 | 9.5 | — | 90.9 | ||||||||||||||||||||||||
Income tax (expense) benefit | (12.8) | (13.7) | (2.4) | 6.2 | (22.7) | ||||||||||||||||||||||||
Net (loss) income attributable to Enhabit | $ | (40.4) | $ | 95.3 | $ | 7.1 | $ | 6.2 | $ | 68.2 | |||||||||||||||||||
Diluted earnings per share(4) |
$ | (0.81) | $ | 1.91 | $ | 0.14 | $ | 0.12 | $ | 1.36 | |||||||||||||||||||
Diluted shares | 49.7 | 49.7 |
Three Months Ended December 31, |
For the Year Ended December 31, |
||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||
Net loss | $ | (5.9) | $ | (94.7) | $ | (79.0) | $ | (38.3) | |||||||||||||||
Interest expense | 12.3 | 8.7 | 43.0 | 15.0 | |||||||||||||||||||
Unusual or nonrecurring items that are not typical of ongoing operations(1) |
11.4 | 2.5 | 21.2 | 9.5 | |||||||||||||||||||
Depreciation and amortization | 7.7 | 8.3 | 30.9 | 33.0 | |||||||||||||||||||
Stock-based compensation | 1.7 | 2.1 | 8.9 | 9.2 | |||||||||||||||||||
Income tax (benefit) expense | (1.5) | (5.1) | (11.4) | 12.8 | |||||||||||||||||||
Net income attributable to noncontrolling interests | (0.5) | (0.5) | (1.5) | (2.1) | |||||||||||||||||||
Impairment of goodwill | — | 109.0 | 85.8 | 109.0 | |||||||||||||||||||
(Gain) loss on disposal or impairment of assets | — | — | (0.3) | 0.1 | |||||||||||||||||||
Stock-based compensation included in overhead allocation | — | — | — | 1.1 | |||||||||||||||||||
Adjusted EBITDA | $ | 25.2 | $ | 30.3 | $ | 97.6 | $ | 149.3 |
Three Months Ended December 31, |
For the Year Ended December 31, |
||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||
Net cash provided by operating activities | $ | 2.8 | $ | 4.1 | $ | 48.4 | $ | 80.1 | |||||||||||||||
Unusual or nonrecurring items not typical of ongoing operations(1) |
11.4 | 2.5 | 21.2 | 9.5 | |||||||||||||||||||
Interest expense excluding amortization of debt discounts and fees | 11.2 | 8.7 | 40.9 | 15.0 | |||||||||||||||||||
Change in assets and liabilities, excluding derivative instruments | 3.1 | 19.2 | (11.9) | 29.2 | |||||||||||||||||||
Current portion of income tax (benefit) expense | (3.0) | (3.3) | 0.2 | 17.1 | |||||||||||||||||||
Net income attributable to noncontrolling interests in continuing operations | (0.5) | (0.5) | (1.5) | (2.1) | |||||||||||||||||||
Other | 0.2 | (0.4) | 0.3 | (0.6) | |||||||||||||||||||
Stock-based compensation included in overhead allocation | — | — | — | 1.1 | |||||||||||||||||||
Adjusted EBITDA | $ | 25.2 | $ | 30.3 | $ | 97.6 | $ | 149.3 |
Three Months Ended December 31, |
For the Year Ended December 31, |
||||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Net cash provided by operating activities | $ | 2.8 | $ | 4.1 | $ | 48.4 | $ | 80.1 | |||||||||||||||
Unusual or nonrecurring items not typical of ongoing operations(1) |
11.4 | 2.5 | 21.2 | 9.5 | |||||||||||||||||||
Other working capital adjustments, including accrued unusual or nonrecurring items | (2.5) | (0.7) | (4.2) | (0.7) | |||||||||||||||||||
Distributions paid to noncontrolling interests of consolidated affiliates | (0.7) | (0.3) | (3.2) | (1.2) | |||||||||||||||||||
Capital expenditures for maintenance | 0.2 | (1.4) | (3.4) | (4.5) | |||||||||||||||||||
Stock-based compensation included in overhead allocation | — | — | — | 1.1 | |||||||||||||||||||
Adjusted free cash flow | $ | 11.2 | $ | 4.2 | $ | 58.8 | $ | 84.3 |
Three Months Ended December 31, |
For the Year Ended December 31, |
||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Gross margin as a percentage of revenue | 48.8 | % | 49.4 | % | 48.8 | % | 50.9 | % | |||||||||||||||
General and administrative expenses | (43.9) | % | (39.7) | % | (42.2) | % | (38.7) | % | |||||||||||||||
Unusual or nonrecurring items that are not typical of ongoing operations(1) |
4.4 | % | 0.9 | % | 2.0 | % | 0.9 | % | |||||||||||||||
Stock-based compensation | 0.6 | % | 0.8 | % | 0.8 | % | 1.1 | % | |||||||||||||||
Noncontrolling interests | (0.2) | % | (0.2) | % | (0.1) | % | (0.2) | % | |||||||||||||||
Other | — | % | 0.3 | % | — | % | (0.1) | % | |||||||||||||||
Adjusted EBITDA Margin | 9.7 | % | 11.5 | % | 9.3 | % | 13.9 | % |